Pfizer coupons

In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products. Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer RxPathways Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. At Pfizer our biotechnology is our foundation. With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus. Learn more. Pfizer Media Relations We encourage everyone to view our press releases, press statements, and press kits to stay up to date on Pfizer news. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists. Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma Read More 04.28.2026 This release contains forward-looking information about an investigational Lyme disease vaccine candidate, PF-07307405 (LB6V, formerly known as VLA15), and a collaboration between Pfizer and Valneva for PF-07307405, including their potential benefits, the results of the Phase 3 VALOR clinical trial and plans to proceed with regulatory. Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the U.S. District Court for the District of Delaware for infringement of patents relating to VYNDAMAX ® (tafamidis), a treatment for cardiomyopathy transthyretin-mediated amyloidosis (ATTR-CM. Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts Financial Finance 03.23.2026 Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial Research and Pipeline Research 03.20.2026 Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Pfizer’s supply chain supports the research, development and manufacturing process by providing flexibility and access to technologies necessary to meet our commitment to patients We are committed to using suppliers that demonstrate strong performance in Environment, Health, and Safety (EHS) management. Learn More About EHS Supply Chain.

Meta: